- Home
- VERI vs LXRX Comparison
VERI vs LXRX Comparison
Compare VERI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERI | LXRX |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.0M | 547.4M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | VERI | LXRX |
|---|---|---|
| Price | $2.98 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $10.00 | $4.63 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.36 | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,637,000.00 | $49,803,000.00 |
| Revenue This Year | $20.56 | N/A |
| Revenue Next Year | $19.11 | $22.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $1.29 | $0.32 |
| 52 Week High | $9.42 | $1.83 |
Technical Indicators
Market Signals| Indicator | VERI | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.86 | 66.31 |
| Support Level | $2.57 | $1.08 |
| Resistance Level | $3.15 | $1.83 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 60.59 | 84.83 |
Price Performance
Historical ComparisonAbout VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.